These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9105649)

  • 1. Inhibitor index: a novel method for measuring pharmacological inhibition of angiotensin-converting enzyme.
    Reneland R; Lithell H
    Blood Press; 1997 Mar; 6(2):103-8. PubMed ID: 9105649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly men.
    Reneland R; Haenni A; Andersson PE; Andrén B; Lithell H
    Blood Press; 1999; 8(1):16-22. PubMed ID: 10412878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition.
    Reneland R; Andersson PE; Haenni A; Lithell H
    Eur J Clin Pharmacol; 1994; 46(5):431-6. PubMed ID: 7957538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of left ventricular wall thickness during ACE-inhibitor treatment of essential hypertension is associated with an increase in insulin mediated skeletal muscle blood flow.
    Andersson PE; Lind L; Andrén B; Hänni A; Reneland R; Berne C; Lithell H
    Blood Press; 1998 May; 7(2):118-26. PubMed ID: 9657539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of insulin resistance by beta-blockade but not ACE-inhibition: long-term treatment with atenolol or trandolapril.
    Reneland R; Alvarez E; Andersson PE; Haenni A; Byberg L; Lithell H
    J Hum Hypertens; 2000 Mar; 14(3):175-80. PubMed ID: 10694831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alterations in insulin sensitivity during angiotensin converting enzyme inhibitor treatment are related to changes in the calcium/magnesium balance.
    Haenni A; Berglund L; Reneland R; Anderssson PE; Lind L; Lithell H
    Am J Hypertens; 1997 Feb; 10(2):145-51. PubMed ID: 9037321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin receptor number in arterial hypertension: response to treatment with fosinopril or atenolol.
    Makris T; Krespi P; Triposkiadis F; Votteas V; Hatzizaharias A; Kyriakidis M
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):494-6. PubMed ID: 9607389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fosinopril versus enalapril in the treatment of hypertension: a double-blind study in 195 patients.
    Hansson L; Forslund T; Höglund C; Istad H; Lederballe-Pedersen O; Kristinsson A; Segaard E; Svensson A; Aärynen M; Wahrenberg H; Wennersten G; Kjellström T
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):1-5. PubMed ID: 8797128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
    Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting response to chronic antihypertensive treatment with fosinopril: the role of angiotensin-converting enzyme gene polymorphism.
    Stavroulakis GA; Makris TK; Krespi PG; Hatzizacharias AN; Gialeraki AE; Anastasiadis G; Triposkiadis P; Kyriakidis M
    Cardiovasc Drugs Ther; 2000 Aug; 14(4):427-32. PubMed ID: 10999650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.
    Hayek T; Attias J; Coleman R; Brodsky S; Smith J; Breslow JL; Keidar S
    Cardiovasc Res; 1999 Dec; 44(3):579-87. PubMed ID: 10690290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro stability of the inhibition of serum converting enzyme by fosinopril.
    Grima M; Barthelmebs M; Stephan D; Welsch M; Imbs JL
    Fundam Clin Pharmacol; 1992; 6(2):83-8. PubMed ID: 1318861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of fosinopril on progression of the asymptomatic carotid atherosclerosis and left ventricular hypertrophy in hypertensive patients].
    Tasić IS; Mijalković D; Djordjević D; Lović B; Janković D; Miladinović-Tasić N; Lović M
    Srp Arh Celok Lek; 2006; 134(3-4):106-13. PubMed ID: 16915750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction.
    Pedersen OD; Gram J; Jeunemaitre X; Billaud E; Jespersen J
    Coron Artery Dis; 1997 May; 8(5):283-91. PubMed ID: 9285181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
    MacFadyen RJ; Lee AF; Morton JJ; Pringle SD; Struthers AD
    Heart; 1999 Jul; 82(1):57-61. PubMed ID: 10377310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled study of the effect of angiotensin converting enzyme inhibition versus calcium-entry blockade on insulin sensitivity in overweight hypertensive patients: Trandolapril Italian Study (TRIS).
    Galletti F; Strazzullo P; Capaldo B; Carretta R; Fabris F; Ferrara LA; Glorioso N; Semplicini A; Mancini M
    J Hypertens; 1999 Mar; 17(3):439-45. PubMed ID: 10100083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin status does not predict the anti-hypertensive response to angiotensin-converting enzyme inhibition in African-Americans. Trandolapril Multicenter Study Group.
    Weir MR; Saunders E
    J Hum Hypertens; 1998 Mar; 12(3):189-94. PubMed ID: 9579769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An effective approach for treating elderly patients with isolated systolic hypertension: results of an Italian multicenter study with fosinopril.
    Leonetti G; Trimarco B; Collatina S; Tosetti A
    Am J Hypertens; 1997 Oct; 10(10 Pt 2):230S-235S. PubMed ID: 9366278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, safety, and pharmacologic effects of fosinopril sodium, an angiotensin-converting enzyme inhibitor in healthy subjects.
    Duchin KL; Waclawski AP; Tu JI; Manning J; Frantz M; Willard DA
    J Clin Pharmacol; 1991 Jan; 31(1):58-64. PubMed ID: 1646240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors.
    Danilov SM; Tovsky SI; Schwartz DE; Dull RO
    J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):374-386. PubMed ID: 28587581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.